A new biosensor made of high entropy alloys is more sensitive than a PCR test at detecting ovarian cancer.
April 23, 2026
Original Paper
Signal–Noise Decoupling at the Heterointerface: A High-Entropy Alloy– Graphene Quantum Dot Architecture for High-Fidelity Electrochemical microRNA-200c Detection
SSRN · 6623842
The Takeaway
This device uses graphene quantum dots and advanced alloys to pull cancer signals out of the blood with zero background noise. It matches the accuracy of gold standard RNA sequencing but delivers results in a fraction of the time. Most cancer tests require expensive lab equipment and days of waiting, but this sensor is compact and provides 100% concordance with clinical results. It could allow for the immediate detection of metastasis during a routine doctor's visit.
From the abstract
The clinical utility of microRNA-200c (miRNA-200c)—a established biomarker for ovarian cancer metastasis and chemoresistance—is constrained by the limited sensitivity and specificity of existing detection methods in biofluids. Here we describe an electrochemical biosensor constructed through coordination-driven assembly of histidine-functionalized B,N-co-doped graphene quantum dots (HBN-GQDs) and MnNiCuMoAu0.1 high-entropy alloy (HEA) nanoparticles. The resulting HEA heterostructure exhibits 9.7